Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
26/03/2025 11:47
March 26 (Reuters) - Avalo Therapeutics Inc AVTX.O: AVALO THERAPEUTICS APPOINTS MICHAEL HEFFERNAN AS CHAIRMAN OF THE BOARD AVALO THERAPEUTICS - GARRY NEIL TO REMAIN AS CEO AND BOARD MEMBER Source text: ID:nGNX8mG9R Further company coverage: AVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%